The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations-Reference-Cited by-同舟云学术

The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations

Published:2018-07-16 Issue:1 Volume:172 Page:151-157
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Barnes-Kedar Inbal,Bernstein-Molho Rinat,Ginzach Nava,Hartmajer Shulamit,Shapira Tamar,Magal Nurit,Kalis Marina Lifshitc,Peretz Tamar,Shohat Mordechai,Basel-Salmon Lina,Friedman Eitan,Bazak Lily,Goldberg Yael^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4887-7/fulltext.html

Reference28 articles.

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689

2. Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S et al (2017) NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017. J Natl Compr Cancer Netw 15:9–20

3. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963–970

4. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A et al (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259–1272

5. Bar-Sade RB, Kruglikova A, Modan B, Gak E, Hirsh-Yechezkel G, Theodor L et al (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7:801–805

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years;Cancer;2024-04-17

2. <I>BRCA1/2</I> mutation spectrum in Armenian patients with breast and ovarian cancers;Siberian journal of oncology;2024-01-03

3. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent;Genetics in Medicine;2023-09

4. Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status;Breast Cancer Research and Treatment;2023-02-02

5. A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia;Breast Cancer Research and Treatment;2022-11-11